Jump to content

Stem cell: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Dobett (talk | contribs)
18 edits
No edit summary
ClueBot (talk | contribs)
1,596,818 edits
m Reverting possible vandalism by Dobett to version by Andcarne. False positive? Report it. Thanks, ClueBot. (655438) (Bot)
Line 1: Line 1:
{{pp-semi-vandalism|small=yes}}
[[Image:Mouse embryonic stem cells.jpg|right|thumb|300px|[[Mus musculus|Mouse]] [[Mammalian embryogenesis|embryo]]nic stem cells with fluorescent marker.]]
[[Image:Human embryonic stem cell colony phase.jpg|right|thumb|300px|Human Embryonic Stem cell colony on mouse embryonic fibroblast feeder layer.]]
'''Stem cells''' are [[Cell (biology)|cells]] found in most, if not all, multi-cellular [[organisms]]. They are characterized by the ability to renew themselves through [[Mitosis|mitotic]] [[cell division]] and [[Cellular differentiation|differentiating]] into a diverse range of specialized cell types. Research in the stem cell field grew out of findings by [[Canada|Canadian]] scientists [[Ernest McCulloch|Ernest A. McCulloch]] and [[James Till|James E. Till]] in the 1960s.<ref>{{cite journal | author = Becker AJ, McCulloch EA, Till JE | title = Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells | journal = Nature | volume = 197 | pages = 452–4 | year = 1963 | pmid = 13970094 | doi=10.1038/197452a0 }}</ref><ref>{{cite journal | author = Siminovitch L, McCulloch EA, Till JE | title = The distribution of colony-forming cells among spleen colonies | journal = Journal of Cellular and Comparative Physiology | volume = 62| pages = 327–36 | year = 1963 | pmid = 14086156 | doi = 10.1002/jcp.1030620313}}</ref>
The two broad types of mammalian stem cells are: '''[[embryonic stem cell]]s''' that are isolated from the [[inner cell mass]] of [[blastocyst]]s, and '''[[adult stem cell]]s''' that are found in adult tissues. In a developing [[embryo]], stem cells can differentiate into all of the specialized embryonic tissues. In [[adult]] organisms, stem cells and [[progenitor cell]]s act as a repair system for the body, replenishing specialized cells, but also maintain the normal turnover of regenerative organs, such as blood, skin or intestinal tissues.

Stem cells can now be grown and transformed into specialized cells with characteristics consistent with cells of various tissues such as muscles or nerves through [[cell culture]]. Highly plastic adult stem cells from a variety of sources, including [[umbilical cord blood]] and [[bone marrow]], are routinely used in medical therapies. Embryonic [[cell line]]s and [[autologous]] embryonic stem cells generated through [[therapeutic cloning]] have also been proposed as promising candidates for future therapies. <ref>{{cite journal | author=Tuch BE | title=Stem cells—a clinical update | journal=[[Australian Family Physician]] | volume=35 | issue=9 | pages=719–21 | year=2006 | pmid=16969445}}</ref>

==Properties==
The classical definition of a stem cell requires that it possess two properties:
* '''''Self-renewal''''' - the ability to go through numerous [[cell cycle|cycles]] of [[cell division]] while maintaining the undifferentiated state.
* '''''Potency''''' - the capacity to differentiate into specialized cell types. In the strictest sense, this requires stem cells to be either '''[[totipotency|totipotent]]''' or '''[[pluripotency|pluripotent]]''' - to be able to give rise to any mature cell type, although '''[[multipotent]]''' or '''[[unipotent cell|unipotent]]''' [[progenitor cell]]s are sometimes referred to as stem cells.

===Potency definitions===
[[Image:Stem cells diagram.png|400px|thumb|right|Pluripotent, embryonic stem cells originate as inner mass cells within a blastocyst. The stem cells can become any tissue in the body, excluding a placenta. Only the morula's cells are totipotent, able to become all tissues and a placenta.]]
''Potency'' specifies the differentiation potential (the potential to differentiate into different cell types) of the stem cell.<ref name=Schoeler>{{cite book|title=Humanbiotechnology as Social Challenge|editor=Nikolaus Knoepffler, Dagmar Schipanski, and Stefan Lorenz Sorgner|pages=28|chapter=The Potential of Stem Cells: An Inventory|author=Hans R. Sch&ouml;ler|publisher=Ashgate Publishing, Ltd|date=2007|isbn=0754657558|isbn13=9780754657552}}</ref>

* '''[[Totipotency|Totipotent]]''' (a.k.a '''omnipotent''') stem cells can differentiate into embryonic and extraembryonic cell types. Such cells can construct a complete, viable, organism.<ref name=Schoeler/> These cells are produced from the fusion of an egg and sperm cell. Cells produced by the first few divisions of the fertilized egg are also totipotent.{{Fact|date=November 2008}}
* '''[[Pluripotency|Pluripotent]]''' stem cells are the descendants of totipotent cells and can differentiate into nearly all cells,<ref name=Schoeler/> i.e. cells derived from any of the three [[germ layer]]s.<ref>{{cite journal |author=Ulloa-Montoya F, Verfaillie CM, Hu WS |title=Culture systems for pluripotent stem cells |journal=J Biosci Bioeng. |volume=100 |issue=1 |pages=12–27 |year=2005 |month=Jul |pmid=16233846 |doi=10.1263/jbb.100.12 }}</ref>
* '''[[Multipotency|Multipotent]]''' stem cells can differentiate into a number of cells, but only those of a closely related family of cells.<ref name=Schoeler/>
* '''[[Oligopotency|Oligopotent]]''' stem cells can differentiate into only a few cells, such as lymphoid or myeloid stem cells.<ref name=Schoeler/>
* '''[[Unipotency|Unipotent]]''' cells can produce only one cell type, their own,<ref name=Schoeler/> but have the property of self-renewal which distinguishes them from non-stem cells (e.g. muscle stem cells).

===Identification===
The practical definition of a stem cell is the functional definition - a cell that has the potential to regenerate tissue over a lifetime. For example, the gold standard test for a bone marrow or hematopoietic stem cell (HSC) is the ability to transplant one cell and save an individual without HSCs. In this case, a stem cell must be able to produce new blood cells and immune cells over a long term, demonstrating potency. It should also be possible to isolate stem cells from the transplanted individual, which can themselves be transplanted into another individual without HSCs, demonstrating that the stem cell was able to self-renew.

Properties of stem cells can be illustrated ''[[in vitro]]'', using methods such as [[mesenchymal stem cell|clonogenic assay]]s, where single cells are characterized by their ability to differentiate and self-renew.<ref>{{cite journal
| author = Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, Ruadkow IA
| title = Precursors for fibroblasts in different populations of hematopoietic cells as detected by the ''in vitro'' colony assay method
| journal = Exp Hematol
| volume = 2
| issue = 2
| pages = 83–92
| year = 1974
| pmid = 4455512
}}</ref><ref>
{{cite journal
| author = Friedenstein AJ, Gorskaja JF, Kulagina NN
| title = Fibroblast precursors in normal and irradiated mouse hematopoietic organs
| journal = Exp Hematol
| volume = 4
| issue = 5
| pages = 267–74
| year = 1976
| pmid = 976387
}}</ref> As well, stem cells can be isolated based on a distinctive set of cell surface markers. However, ''in vitro'' culture conditions can alter the behavior of cells, making it unclear whether the cells will behave in a similar manner ''[[in vivo]]''. Considerable debate exists whether some proposed adult cell populations are truly stem cells.

==Embryonic==
{{main|Embryonic stem cell}}

'''Embryonic stem cell lines''' (ES cell lines) are cultures of cells derived from the [[epiblast]] tissue of the [[inner cell mass]] (ICM) of a [[blastocyst]] or earlier [[morula]] stage embryos.<ref>
{{cite news
|url=http://www.foxnews.com/story/0,2933,210078,00.html
|publisher=Fox News
|title=New Stem-Cell Procedure Doesn't Harm Embryos, Company Claims
}}</ref> A blastocyst is an early stage [[embryo]]—approximately four to five days old in humans and consisting of 50–150 cells. ES cells are [[pluripotent]] and give rise during development to all derivatives of the three primary [[germ layer]]s: ectoderm, endoderm and mesoderm. In other words, they can develop into each of the more than 200 cell types of the adult [[human body|body]] when given sufficient and necessary stimulation for a specific cell type. They do not contribute to the extra-embryonic membranes or the [[placenta]].

Nearly all research to date has taken place using mouse embryonic stem cells (mES) or human embryonic stem cells (hES). Both have the essential stem cell characteristics, yet they require very different environments in order to maintain an undifferentiated state. Mouse ES cells are grown on a layer of gelatin and require the presence of Leukemia Inhibitory Factor (LIF).<ref>
{{cite web
|url=https://catalog.invitrogen.com/index.cfm?fuseaction=iProtocol.unitSectionTree&treeNodeID=9E662600C6C10276D8E040E99EA33BB0
|title=Mouse Embryonic Stem (ES) Cell Culture-Current Protocols in Molecular Biology
}}</ref> Human ES cells are grown on a feeder layer of mouse embryonic [[fibroblasts]] (MEFs) and require the presence of basic Fibroblast Growth Factor (bFGF or FGF-2).<ref>
{{cite web
|url=http://stemcells.nih.gov/research/NIHresearch/scunit/culture.asp
|title=Culture of Human Embryonic Stem Cells (hESC)
|publisher=National Institutes of Health
}}</ref> Without optimal culture conditions or genetic manipulation,<ref>
{{cite journal
|author=Chambers I, Colby D, Robertson M, ''et al''
|title=Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells
|journal=Cell
|volume=113
|issue=5
|pages=643–55
|year=2003
|pmid=12787505
|doi=10.1016/S0092-8674(03)00392-1
}}</ref> embryonic stem cells will rapidly differentiate.

A human embryonic stem cell is also defined by the presence of several transcription factors and cell surface proteins. The transcription factors [[Oct-4]], [[Nanog]], and [[SOX2]] form the core regulatory network that ensures the suppression of genes that lead to differentiation and the maintenance of pluripotency.<ref>
{{cite journal
|author=Boyer LA, Lee TI, Cole MF, ''et al''
|title=Core transcriptional regulatory circuitry in human embryonic stem cells
|journal=Cell
|volume=122
|issue=6
|pages=947–56
|year=2005
|pmid=16153702
|doi=10.1016/j.cell.2005.08.020
}}</ref> The cell surface antigens most commonly used to identify hES cells are the glycolipids SSEA3 and SSEA4 and the keratan sulfate antigens Tra-1-60 and Tra-1-81. The molecular definition of a stem cell includes many more proteins and continues to be a topic of research.<ref>
{{cite journal
|author=Adewumi O, Aflatoonian B, Ahrlund-Richter L, ''et al''
|title=Characterization of human embryonic stem cell lines by the International Stem Cell Initiative
|journal=Nat. Biotechnol
|volume=25
|issue=7
|pages=803–16
|year=2007
|pmid=17572666
|doi=10.1038/nbt1318
}}</ref>

After nearly ten years of research<ref>
{{cite journal
| author = Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V, Jones J
| title = Embryonic stem cell lines derived from human blastocysts
| journal = Science
| volume = 282
| issue = 5391
| pages = 1145–7
| year = 1998
| pmid = 9804556
| doi = 10.1126/science.282.5391.1145
}}</ref>, there are no approved treatments or human trials using embryonic stem cells. ES cells, being pluripotent cells, require specific signals for correct differentiation - if injected directly into another body, ES cells will differentiate into many different types of cells, causing a [[teratoma]]. Differentiating ES cells into usable cells while avoiding transplant rejection are just a few of the hurdles that embryonic stem cell researchers still face.<ref>
{{cite journal
|author=Wu DC, Boyd AS, Wood KJ
|title=Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine
|journal=Front Biosci
|volume=12
|issue=
|pages=4525–35
|year=2007
|pmid=17485394
|doi=10.2741/2407
}}</ref> Many nations currently have [[Moratorium (law)|moratoria]] on either ES cell research or the production of new ES cell lines. Because of their combined abilities of unlimited expansion and pluripotency, embryonic stem cells remain a theoretically potential source for regenerative medicine and tissue replacement after injury or disease.

==Fetal==
Fetal stem cells are primitive cell types found in the organs of fetuses <ref name="isbn981-256-126-9">
{{cite book
|author=editors, Ariff Bongso & Eng Hin Lee ; forewords by Sydney Brenner & Philip Yeo.
|title=Stem Cells: From Benchtop to Bedside
|publisher=World Scientific
|location=
|year=2005
|pages=
|isbn=981-256-126-9
|oclc=
}}</ref>. The classification of fetal stem cells remains unclear and this type of stem cell is currently often grouped into an adult stem cell. However, a more clear distinction between the two cell types appears necessary.

==Adult==
{{main|Adult stem cell}}

[[Image:Stem cell division and differentiation.svg|thumb|160px|'''Stem cell division and differentiation.''' A - stem cell; B - progenitor cell; C - differentiated cell; 1 - symmetric stem cell division; 2 - asymmetric stem cell division; 3 - progenitor division; 4 - terminal differentiation]]

The term '''adult stem cell''' refers to any cell which is found in a developed organism that has two properties: the ability to divide and create another cell like itself and also divide and create a cell more differentiated than itself. Also known as '''[[somatic]]''' (from Greek Σωματικóς, "of the body") stem cells and '''germline''' (giving rise to gametes) stem cells, they can be found in children, as well as adults.<ref>
{{cite journal
|author=Jiang Y, Jahagirdar BN, Reinhardt RL, ''et al''
|title=Pluripotency of mesenchymal stem cells derived from adult marrow
|journal=Nature
|volume=418
|issue=6893
|pages=41–9
|year=2002
|pmid=12077603
|doi=10.1038/nature00870
}}</ref>

Pluripotent adult stem cells are rare and generally small in number but can be found in a number of tissues including umbilical cord blood.<ref>
{{cite journal
|author=Ratajczak MZ, Machalinski B, Wojakowski W, Ratajczak J, Kucia M
|title=A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues
|journal=Leukemia
|volume=21
|issue=5
|pages=860–7
|year=2007
|pmid=17344915
|doi=10.1038/sj.leu.2404630
}}</ref> A great deal of adult stem cell research has focused on clarifying their capacity to divide or self-renew indefinitely and their differentiation potential.<ref>
{{cite journal
| author = Gardner RL
| title = Stem cells: potency, plasticity and public perception
| journal = Journal of Anatomy
| volume = 200
| issue = 3
| pages = 277–82
| year = 2002
| pmid = 12033732
| doi=10.1046/j.1469-7580.2002.00029.x
}}</ref> In mice, pluripotent stem cells are directly generated from adult fibroblast cultures. Unfortunately, many mice don't live long with stem cell organs.<ref>
{{cite journal
|author=Takahashi K, Yamanaka S
|title=Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
|journal=Cell
|volume=126
|issue=4
|pages=663–76
|year=2006
|pmid=16904174
|doi=10.1016/j.cell.2006.07.024}}</ref>

Most adult stem cells are lineage-restricted ([[multipotent]]) and are generally referred to by their tissue origin ([[mesenchymal stem cell]], adipose-derived stem cell, [[endothelial stem cell]], etc.).<ref>
{{cite journal
|author=Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC
|title=Review: ex vivo engineering of living tissues with adult stem cells
|journal=Tissue Eng
|volume=12
|issue=11
|pages=3007–19
|year=2006
|pmid=17518617
|doi=10.1089/ten.2006.12.3007
}}</ref><ref>
{{cite journal
|author=Gimble JM, Katz AJ, Bunnell BA
|title=Adipose-derived stem cells for regenerative medicine
|journal=Circ Res
|volume=100
|issue=9
|pages=1249–60
|year=2007
|pmid=17495232
|doi=10.1161/01.RES.0000265074.83288.09
}}</ref>

Adult stem cell treatments have been successfully used for many years to treat leukemia and related bone/blood cancers through bone marrow transplants.<ref>
{{cite web
|url=http://www.ucsfhealth.org/childrens/medical_services/cancer/bmt/treatments/leukemia.html
|title=Bone Marrow Transplant
}}</ref> Adult stem cells are also used in veterinary medicine to treat tendon and ligament injuries in horses.<ref>{{cite news
|first=Ed
|last=Kane
|title=Stem-cell therapy shows promise for horse soft-tissue injury, disease
|url=http://www.dvmnews.com/dvm/Equine+Medicine/Stem-cell-therapy-shows-promise-for-horse-soft-tis/ArticleStandard/Article/detail/515503
|publisher=DVM Newsmagazine
|date=2008-05-01
|accessdate=2008-06-12
}}</ref> The use of adult stem cells in research and therapy is not as [[Stem cell controversy|controversial]] as [[embryonic stem cell]]s, because the production of adult stem cells does not require the destruction of an [[embryo]]. Additionally, because in some instances adult stem cells can be obtained from the intended recipient, (an [[autograft]]) the risk of rejection is essentially non-existent in these situations. Consequently, more US government funding is being provided for adult stem cell research.<ref>
{{cite web
|url=http://www.hhs.gov/news/press/2004pres/20040714b.html
|publisher=US Department of Health and Human Services
|title=Stem Cell FAQ
|year=2004
}}</ref>

==Lineage==
{{main|Stem cell line}}
To ensure self-renewal, stem cells undergo two types of cell division (see ''Stem cell division and differentiation'' diagram). Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division, on the other hand, produces only one stem cell and a [[progenitor cell]] with limited self-renewal potential. Progenitors can go through several rounds of cell division before terminally [[cell differentiation|differentiating]] into a mature cell. It is possible that the molecular distinction between symmetric and asymmetric divisions lies in differential segregation of cell membrane proteins (such as [[Receptor (biochemistry)|receptors]]) between the daughter cells.<ref>
{{cite journal
|author=Beckmann J, Scheitza S, Wernet P, Fischer JC, Giebel B
|title=Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins
|journal=Blood
|volume=109
|issue=12
|pages=5494–501
|year=2007
|pmid=17332245
|doi=10.1182/blood-2006-11-055921
}}</ref>

An alternative theory is that stem cells remain undifferentiated due to environmental cues in their particular niche. Stem cells differentiate when they leave that niche or no longer receive those signals. Studies in ''Drosophila'' germarium have identified the signals dpp and adherens junctions that prevent germarium stem cells from differentiating.<ref>
{{cite journal
| author = Xie T, Spradling A
| title = decapentaplegic is essential for the maintenance and division of germline stem cells in the Drosophila ovary
| journal = Cell
| volume = 94
| issue = 2
| pages = 251–60
| year = 1998
| pmid = 9695953
| doi = 10.1016/S0092-8674(00)81424-5
}}</ref><ref>
{{cite journal
| author = Song X, Zhu C, Doan C, Xie T
| title = Germline stem cells anchored by adherens junctions in the Drosophila ovary niches
| journal = Science
| volume = 296
| issue = 5574
| pages = 1855–7
| year = 2002
| pmid = 12052957
| doi=10.1126/science.1069871
}}</ref>

{{main|Induced Pluripotent Stem Cell}}
The signals that lead to reprogramming of cells to an embryonic-like state are also being investigated. These signal pathways include several [[transcription factor]]s including the [[oncogene]] [[Myc|c-Myc]]. Initial studies indicate that transformation of mice cells with a combination of these anti-differentiation signals can reverse differentiation and may allow adult cells to become pluripotent.<ref>
{{cite journal
| author = Takahashi K, Yamanaka S
| title = Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
| journal = Cell
| volume = 126
| issue = 4
| pages = 663–76
| year = 2006
| pmid = 16904174
| doi=10.1016/j.cell.2006.07.024
}}</ref> However, the need to transform these cells with an oncogene may prevent the use of this approach in therapy.

==Treatments==
{{main|Stem cell treatments}}
Medical researchers believe that stem cell therapy has the potential to dramatically change the treatment of human disease. A number of adult stem cell therapies already exist, particularly [[bone marrow transplant]]s that are used to treat [[leukemia]].<ref>
{{cite journal
|author=Gahrton G, Björkstrand B
|title=Progress in haematopoietic stem cell transplantation for multiple myeloma
|journal=J Intern Med
|volume=248
|issue=3
|pages=185–201
|year=2000
|pmid= 10971785
|doi=10.1046/j.1365-2796.2000.00706.x
}}</ref> In the future, medical researchers anticipate being able to use technologies derived from stem cell research to treat a wider variety of diseases including [[cancer]], [[Parkinson's disease]], [[spinal cord injuries]], [[Amyotrophic lateral sclerosis]], [[multiple sclerosis]], and [[muscle]] damage, amongst a number of other impairments and conditions.<ref>
{{cite journal
|author=Lindvall O
|title=Stem cells for cell therapy in Parkinson's disease
|journal=Pharmacol Res
|volume=47
|issue=4
|pages=279–87
|year=2003
|pmid = 12644384
|doi=10.1016/S1043-6618(03)00037-9
}}</ref><ref>
}}</ref><ref>
{{cite journal
{{cite journal
Line 4: Line 317:
|title=Cell replacement therapy in neurological disease
|title=Cell replacement therapy in neurological disease
|journal=Philos Trans R Soc Lond B Biol Sci
|journal=Philos Trans R Soc Lond B Biol Sci
|volume=361grdfhgtrfdyh5rt6y
|volume=361
|issue=1473
|issue=1473
|pages=1463–75
|pages=1463–75

Revision as of 16:01, 1 April 2009

Mouse embryonic stem cells with fluorescent marker.
Human Embryonic Stem cell colony on mouse embryonic fibroblast feeder layer.

Stem cells are cells found in most, if not all, multi-cellular organisms. They are characterized by the ability to renew themselves through mitotic cell division and differentiating into a diverse range of specialized cell types. Research in the stem cell field grew out of findings by Canadian scientists Ernest A. McCulloch and James E. Till in the 1960s.[1][2] The two broad types of mammalian stem cells are: embryonic stem cells that are isolated from the inner cell mass of blastocysts, and adult stem cells that are found in adult tissues. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing specialized cells, but also maintain the normal turnover of regenerative organs, such as blood, skin or intestinal tissues.

Stem cells can now be grown and transformed into specialized cells with characteristics consistent with cells of various tissues such as muscles or nerves through cell culture. Highly plastic adult stem cells from a variety of sources, including umbilical cord blood and bone marrow, are routinely used in medical therapies. Embryonic cell lines and autologous embryonic stem cells generated through therapeutic cloning have also been proposed as promising candidates for future therapies. [3]

Properties

The classical definition of a stem cell requires that it possess two properties:

  • Self-renewal - the ability to go through numerous cycles of cell division while maintaining the undifferentiated state.
  • Potency - the capacity to differentiate into specialized cell types. In the strictest sense, this requires stem cells to be either totipotent or pluripotent - to be able to give rise to any mature cell type, although multipotent or unipotent progenitor cells are sometimes referred to as stem cells.

Potency definitions

Pluripotent, embryonic stem cells originate as inner mass cells within a blastocyst. The stem cells can become any tissue in the body, excluding a placenta. Only the morula's cells are totipotent, able to become all tissues and a placenta.

Potency specifies the differentiation potential (the potential to differentiate into different cell types) of the stem cell.[4]

  • Totipotent (a.k.a omnipotent) stem cells can differentiate into embryonic and extraembryonic cell types. Such cells can construct a complete, viable, organism.[4] These cells are produced from the fusion of an egg and sperm cell. Cells produced by the first few divisions of the fertilized egg are also totipotent.[citation needed]
  • Pluripotent stem cells are the descendants of totipotent cells and can differentiate into nearly all cells,[4] i.e. cells derived from any of the three germ layers.[5]
  • Multipotent stem cells can differentiate into a number of cells, but only those of a closely related family of cells.[4]
  • Oligopotent stem cells can differentiate into only a few cells, such as lymphoid or myeloid stem cells.[4]
  • Unipotent cells can produce only one cell type, their own,[4] but have the property of self-renewal which distinguishes them from non-stem cells (e.g. muscle stem cells).

Identification

The practical definition of a stem cell is the functional definition - a cell that has the potential to regenerate tissue over a lifetime. For example, the gold standard test for a bone marrow or hematopoietic stem cell (HSC) is the ability to transplant one cell and save an individual without HSCs. In this case, a stem cell must be able to produce new blood cells and immune cells over a long term, demonstrating potency. It should also be possible to isolate stem cells from the transplanted individual, which can themselves be transplanted into another individual without HSCs, demonstrating that the stem cell was able to self-renew.

Properties of stem cells can be illustrated in vitro, using methods such as clonogenic assays, where single cells are characterized by their ability to differentiate and self-renew.[6][7] As well, stem cells can be isolated based on a distinctive set of cell surface markers. However, in vitro culture conditions can alter the behavior of cells, making it unclear whether the cells will behave in a similar manner in vivo. Considerable debate exists whether some proposed adult cell populations are truly stem cells.

Embryonic

Main article: Embryonic stem cell

Embryonic stem cell lines (ES cell lines) are cultures of cells derived from the epiblast tissue of the inner cell mass (ICM) of a blastocyst or earlier morula stage embryos.[8] A blastocyst is an early stage embryo—approximately four to five days old in humans and consisting of 50–150 cells. ES cells are pluripotent and give rise during development to all derivatives of the three primary germ layers: ectoderm, endoderm and mesoderm. In other words, they can develop into each of the more than 200 cell types of the adult body when given sufficient and necessary stimulation for a specific cell type. They do not contribute to the extra-embryonic membranes or the placenta.

Nearly all research to date has taken place using mouse embryonic stem cells (mES) or human embryonic stem cells (hES). Both have the essential stem cell characteristics, yet they require very different environments in order to maintain an undifferentiated state. Mouse ES cells are grown on a layer of gelatin and require the presence of Leukemia Inhibitory Factor (LIF).[9] Human ES cells are grown on a feeder layer of mouse embryonic fibroblasts (MEFs) and require the presence of basic Fibroblast Growth Factor (bFGF or FGF-2).[10] Without optimal culture conditions or genetic manipulation,[11] embryonic stem cells will rapidly differentiate.

A human embryonic stem cell is also defined by the presence of several transcription factors and cell surface proteins. The transcription factors Oct-4, Nanog, and SOX2 form the core regulatory network that ensures the suppression of genes that lead to differentiation and the maintenance of pluripotency.[12] The cell surface antigens most commonly used to identify hES cells are the glycolipids SSEA3 and SSEA4 and the keratan sulfate antigens Tra-1-60 and Tra-1-81. The molecular definition of a stem cell includes many more proteins and continues to be a topic of research.[13]

After nearly ten years of research[14], there are no approved treatments or human trials using embryonic stem cells. ES cells, being pluripotent cells, require specific signals for correct differentiation - if injected directly into another body, ES cells will differentiate into many different types of cells, causing a teratoma. Differentiating ES cells into usable cells while avoiding transplant rejection are just a few of the hurdles that embryonic stem cell researchers still face.[15] Many nations currently have moratoria on either ES cell research or the production of new ES cell lines. Because of their combined abilities of unlimited expansion and pluripotency, embryonic stem cells remain a theoretically potential source for regenerative medicine and tissue replacement after injury or disease.

Fetal

Fetal stem cells are primitive cell types found in the organs of fetuses [16]. The classification of fetal stem cells remains unclear and this type of stem cell is currently often grouped into an adult stem cell. However, a more clear distinction between the two cell types appears necessary.

Adult

Main article: Adult stem cell
Stem cell division and differentiation. A - stem cell; B - progenitor cell; C - differentiated cell; 1 - symmetric stem cell division; 2 - asymmetric stem cell division; 3 - progenitor division; 4 - terminal differentiation

The term adult stem cell refers to any cell which is found in a developed organism that has two properties: the ability to divide and create another cell like itself and also divide and create a cell more differentiated than itself. Also known as somatic (from Greek Σωματικóς, "of the body") stem cells and germline (giving rise to gametes) stem cells, they can be found in children, as well as adults.[17]

Pluripotent adult stem cells are rare and generally small in number but can be found in a number of tissues including umbilical cord blood.[18] A great deal of adult stem cell research has focused on clarifying their capacity to divide or self-renew indefinitely and their differentiation potential.[19] In mice, pluripotent stem cells are directly generated from adult fibroblast cultures. Unfortunately, many mice don't live long with stem cell organs.[20]

Most adult stem cells are lineage-restricted (multipotent) and are generally referred to by their tissue origin (mesenchymal stem cell, adipose-derived stem cell, endothelial stem cell, etc.).[21][22]

Adult stem cell treatments have been successfully used for many years to treat leukemia and related bone/blood cancers through bone marrow transplants.[23] Adult stem cells are also used in veterinary medicine to treat tendon and ligament injuries in horses.[24] The use of adult stem cells in research and therapy is not as controversial as embryonic stem cells, because the production of adult stem cells does not require the destruction of an embryo. Additionally, because in some instances adult stem cells can be obtained from the intended recipient, (an autograft) the risk of rejection is essentially non-existent in these situations. Consequently, more US government funding is being provided for adult stem cell research.[25]

Lineage

Main article: Stem cell line

To ensure self-renewal, stem cells undergo two types of cell division (see Stem cell division and differentiation diagram). Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division, on the other hand, produces only one stem cell and a progenitor cell with limited self-renewal potential. Progenitors can go through several rounds of cell division before terminally differentiating into a mature cell. It is possible that the molecular distinction between symmetric and asymmetric divisions lies in differential segregation of cell membrane proteins (such as receptors) between the daughter cells.[26]

An alternative theory is that stem cells remain undifferentiated due to environmental cues in their particular niche. Stem cells differentiate when they leave that niche or no longer receive those signals. Studies in Drosophila germarium have identified the signals dpp and adherens junctions that prevent germarium stem cells from differentiating.[27][28]

Main article: Induced Pluripotent Stem Cell

The signals that lead to reprogramming of cells to an embryonic-like state are also being investigated. These signal pathways include several transcription factors including the oncogene c-Myc. Initial studies indicate that transformation of mice cells with a combination of these anti-differentiation signals can reverse differentiation and may allow adult cells to become pluripotent.[29] However, the need to transform these cells with an oncogene may prevent the use of this approach in therapy.

Treatments

Main article: Stem cell treatments

Medical researchers believe that stem cell therapy has the potential to dramatically change the treatment of human disease. A number of adult stem cell therapies already exist, particularly bone marrow transplants that are used to treat leukemia.[30] In the future, medical researchers anticipate being able to use technologies derived from stem cell research to treat a wider variety of diseases including cancer, Parkinson's disease, spinal cord injuries, Amyotrophic lateral sclerosis, multiple sclerosis, and muscle damage, amongst a number of other impairments and conditions.[31][32] However, there still exists a great deal of social and scientific uncertainty surrounding stem cell research, which could possibly be overcome through public debate and future research, and further education of the public.

Stem cells, however, are already used extensively in research, and some scientists do not see cell therapy as the first goal of the research, but see the investigation of stem cells as a goal worthy in itself.[33]

Controversy surrounding research

Main article: Stem cell controversy

There exists a widespread controversy over human embryonic stem cell research that emanates from the techniques used in the creation and usage of stem cells. Human embryonic stem cell research is controversial because, with the present state of technology, starting a stem cell line requires the destruction of a human embryo and/or therapeutic cloning. However, recently, it has been shown in principle that adult stem cell lines can be manipulated to generate embryonic-like stem cell lines using a single-cell biopsy similar to that used in preimplantation genetic diagnosis that may allow stem cell creation without embryonic destruction.[34] It is not the entire field of stem cell research, but the specific field of human embryonic stem cell research that is at the centre of an ethical debate.

Opponents of the research argue that embryonic stem cell technologies are a slippery slope to reproductive cloning and can fundamentally devalue human life. Those in the pro-life movement argue that a human embryo is a human life that is entitled to protection.

Contrarily, supporters of embryonic stem cell research argue that such research should be pursued because the resultant treatments could have significant medical potential. It is also noted that excess embryos created for in vitro fertilization could be donated with consent and used for the research.

The ensuing debate has prompted authorities around the world to seek regulatory frameworks and highlighted the fact that stem cell research represents a social and ethical challenge.

Key research events

  • 1908 - The term "stem cell" was proposed for scientific use by the Russian histologist Alexander Maksimov (1874–1928) at congress of hematologic society in Berlin. It postulated existence of haematopoietic stem cells.
  • 1960s - Joseph Altman and Gopal Das present scientific evidence of adult neurogenesis, ongoing stem cell activity in the brain; their reports contradict Cajal's "no new neurons" dogma and are largely ignored.
  • 1963 - McCulloch and Till illustrate the presence of self-renewing cells in mouse bone marrow.
  • 1968 - Bone marrow transplant between two siblings successfully treats SCID.
  • 1978 - Haematopoietic stem cells are discovered in human cord blood.
  • 1981 - Mouse embryonic stem cells are derived from the inner cell mass by scientists Martin Evans, Matthew Kaufman, and Gail R. Martin. Gail Martin is attributed for coining the term "Embryonic Stem Cell".
  • 1992 - Neural stem cells are cultured in vitro as neurospheres.
  • 1997 - Leukemia is shown to originate from a haematopoietic stem cell, the first direct evidence for cancer stem cells.
  • 1998 - James Thomson and coworkers derive the first human embryonic stem cell line at the University of Wisconsin-Madison.[35]
  • 2000s - Several reports of adult stem cell plasticity are published.
  • 2001 - Scientists at Advanced Cell Technology clone first early (four- to six-cell stage) human embryos for the purpose of generating embryonic stem cells.[36]
  • 2003 - Dr. Songtao Shi of NIH discovers new source of adult stem cells in children's primary teeth.[37]
  • 2004–2005 - Korean researcher Hwang Woo-Suk claims to have created several human embryonic stem cell lines from unfertilised human oocytes. The lines were later shown to be fabricated.
  • 2005 - Researchers at Kingston University in England claim to have discovered a third category of stem cell, dubbed cord-blood-derived embryonic-like stem cells (CBEs), derived from umbilical cord blood. The group claims these cells are able to differentiate into more types of tissue than adult stem cells.
  • August 2006 - Rat Induced pluripotent stem cells: the journal Cell publishes Kazutoshi Takahashi and Shinya Yamanaka.[38]
  • October 2006 - Scientists at Newcastle University in England create the first ever artificial liver cells using umbilical cord blood stem cells.[39][40]
  • January 2007 - Scientists at Wake Forest University led by Dr. Anthony Atala and Harvard University report discovery of a new type of stem cell in amniotic fluid.[41] This may potentially provide an alternative to embryonic stem cells for use in research and therapy.[42]
  • June 2007 - Research reported by three different groups shows that normal skin cells can be reprogrammed to an embryonic state in mice.[43] In the same month, scientist Shoukhrat Mitalipov reports the first successful creation of a primate stem cell line through somatic cell nuclear transfer[44]
  • October 2007 - Mario Capecchi, Martin Evans, and Oliver Smithies win the 2007 Nobel Prize for Physiology or Medicine for their work on embryonic stem cells from mice using gene targeting strategies producing genetically engineered mice (known as knockout mice) for gene research.[45]
  • November 2007 - Human induced pluripotent stem cells: Two similar papers released by their respective journals prior to formal publication: in Cell by Kazutoshi Takahashi and Shinya Yamanaka, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors",[46] and in Science by Junying Yu, et al., from the research group of James Thomson, "Induced pluripotent stem cell lines derived from human somatic cells":[47] pluripotent stem cells generated from mature human fibroblasts. It is possible now to produce a stem cell from almost any other human cell instead of using embryos as needed previously, albeit the risk of tumorigenesis due to c-myc and retroviral gene transfer remains to be determined.
  • January 2008 - Robert Lanza and colleagues at Advanced Cell Technology and UCSF create the first human embryonic stem cells without destruction of the embryo[48]
  • January 2008 - Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts[49]
  • February 2008 - Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach: these iPS cells seem to be more similar to embryonic stem cells than the previous developed iPS cells and not tumorigenic, moreover genes that are required for iPS cells do not need to be inserted into specific sites, which encourages the development of non-viral reprogramming techniques. [50][51]
  • March 2008-The first published study of successful cartilage regeneration in the human knee using autologous adult mesenchymal stem cells is published by Clinicians from Regenerative Sciences[52]
  • October 2008 - Sabine Conrad and colleagues at Tübingen, Germany generate pluripotent stem cells from spermatogonial cells of adult human testis by culturing the cells in vitro under leukemia inhibitory factor (LIF) supplementation.[53]
  • 30 October 2008 - Embryonic-like stem cells from a single human hair.[54]
  • 1 March 2009 - Andras Nagy, Keisuke Kaji, et al. discover a way to produce embryonic-like stem cells from normal adult cells by using a novel "wrapping" procedure to deliver specific genes to adult cells to reprogram them into stem cells without the risks of using a virus to make the change.[55][56][57] The use of electroporation is said to allow for the temporary insertion of genes into the cell.[58][59]
  • 05 March 2009 Australian scientists find a way to improve chemotherapy of mouse muscle stem cells.[60]
  • 09 March 2009 US President Obama lifted federal funding limits on human embryonic instituted by former President Bush.[61]

Funding & policy debate in the US

  • 1993 - As per the National Institutes of Health Revitalization Act, Congress and President Bill Clinton give the NIH direct authority to fund human embryo research for the first time.[62]
  • 1995 - The U.S. Congress passes an appropriations bill attached to which is a rider, the Dickey Amendment which prohibited federally appropriated funds to be used for research where human embryos would be either created or destroyed. President Clinton signs the bill into law. This predates the creation of the first human embryonic stem cell lines.
  • 1999 - After the creation of the first human embryonic stem cell lines in 1998 by James Thomson of the University of Wisconsin, Harriet Rabb, the top lawyer at the Department of Health and Human Services, releases a legal opinion that would set the course for Clinton Administration policy. Federal funds, obviously, could not be used to derive stem cell lines (because derivation involves embryo destruction). However, she concludes that because human embryonic stem cells "are not a human embryo within the statutory definition," the Dickey-Wicker Amendment does not apply to them. The NIH was therefore free to give federal funding to experiments involving the cells themselves. President Clinton strongly endorses the new guidelines, noting that human embryonic stem cell research promised "potentially staggering benefits." And with the guidelines in place, the NIH begins accepting grant proposals from scientists.[62]
  • 2001–2006 - U.S. President George W. Bush signs an executive order which restricts federally-funded stem cell research on embryonic stem cells to the already derived cell lines. He supports federal funding for embryonic stem cell research on the already existing lines of approximately $100 million and $250 million for research on adult and animal stem cells.
  • 02 November 2004 - California voters approve Proposition 71, which provides $3 billion in state funds over ten years to human embryonic stem cell research.
  • 5 May 2006 - Senator Rick Santorum introduces bill number S. 2754, or the Alternative Pluripotent Stem Cell Therapies Enhancement Act, into the U.S. Senate.
  • 18 July 2006 - The U.S. Senate passes the Stem Cell Research Enhancement Act H.R. 810 and votes down Senator Santorum's S. 2754.
  • 19 July 2006 - President George W. Bush vetoes House Resolution 810 Stem Cell Research Enhancement Act, a bill that would have reversed the Dickey Amendment which made it illegal for federal money to be used for research where stem cells are derived from the destruction of an embryo.
  • 07 November 2006 - The people of the U.S. state of Missouri passed Amendment 2, which allows usage of any stem cell research and therapy allowed under federal law, but prohibits human reproductive cloning.[63]
  • 16 February 2007 – The California Institute for Regenerative Medicine became the biggest financial backer of human embryonic stem cell research in the United States when they awarded nearly $45 million in research grants.[64]
  • 04 November 2008 - The people of the U.S. state of Michigan passed Proposal 08-2, allowing Michigan researchers to make embryonic stem cell cultures from excess embryos donated from fertility treatments.[65]
  • 23 January 2009 - The FDA approves clinical trials for human embryonic stem cell therapy.[66]
  • 9 March 2009 - President Barack Obama signs an executive order reversing federal opposition to embryonic Stem Cell research.[67]

See also

References

  1. ^ Becker AJ, McCulloch EA, Till JE (1963). "Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells". Nature. 197: 452–4. doi:10.1038/197452a0. PMID 13970094.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ Siminovitch L, McCulloch EA, Till JE (1963). "The distribution of colony-forming cells among spleen colonies". Journal of Cellular and Comparative Physiology. 62: 327–36. doi:10.1002/jcp.1030620313. PMID 14086156.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ Tuch BE (2006). "Stem cells—a clinical update". Australian Family Physician. 35 (9): 719–21. PMID 16969445.
  4. ^ a b c d e f Hans R. Schöler (2007). "The Potential of Stem Cells: An Inventory". In Nikolaus Knoepffler, Dagmar Schipanski, and Stefan Lorenz Sorgner (ed.). Humanbiotechnology as Social Challenge. Ashgate Publishing, Ltd. p. 28. ISBN 0754657558. {{cite book}}: Unknown parameter |isbn13= ignored (help)CS1 maint: multiple names: authors list (link)
  5. ^ Ulloa-Montoya F, Verfaillie CM, Hu WS (2005). "Culture systems for pluripotent stem cells". J Biosci Bioeng. 100 (1): 12–27. doi:10.1263/jbb.100.12. PMID 16233846. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  6. ^ Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, Ruadkow IA (1974). "Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method". Exp Hematol. 2 (2): 83–92. PMID 4455512.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ^ Friedenstein AJ, Gorskaja JF, Kulagina NN (1976). "Fibroblast precursors in normal and irradiated mouse hematopoietic organs". Exp Hematol. 4 (5): 267–74. PMID 976387.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  8. ^ "New Stem-Cell Procedure Doesn't Harm Embryos, Company Claims". Fox News.
  9. ^ "Mouse Embryonic Stem (ES) Cell Culture-Current Protocols in Molecular Biology".
  10. ^ "Culture of Human Embryonic Stem Cells (hESC)". National Institutes of Health.
  11. ^ Chambers I, Colby D, Robertson M; et al. (2003). "Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells". Cell. 113 (5): 643–55. doi:10.1016/S0092-8674(03)00392-1. PMID 12787505. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  12. ^ Boyer LA, Lee TI, Cole MF; et al. (2005). "Core transcriptional regulatory circuitry in human embryonic stem cells". Cell. 122 (6): 947–56. doi:10.1016/j.cell.2005.08.020. PMID 16153702. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  13. ^ Adewumi O, Aflatoonian B, Ahrlund-Richter L; et al. (2007). "Characterization of human embryonic stem cell lines by the International Stem Cell Initiative". Nat. Biotechnol. 25 (7): 803–16. doi:10.1038/nbt1318. PMID 17572666. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  14. ^ Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V, Jones J (1998). "Embryonic stem cell lines derived from human blastocysts". Science. 282 (5391): 1145–7. doi:10.1126/science.282.5391.1145. PMID 9804556.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. ^ Wu DC, Boyd AS, Wood KJ (2007). "Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine". Front Biosci. 12: 4525–35. doi:10.2741/2407. PMID 17485394.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  16. ^ editors, Ariff Bongso & Eng Hin Lee ; forewords by Sydney Brenner & Philip Yeo. (2005). Stem Cells: From Benchtop to Bedside. World Scientific. ISBN 981-256-126-9. {{cite book}}: |author= has generic name (help)CS1 maint: multiple names: authors list (link)
  17. ^ Jiang Y, Jahagirdar BN, Reinhardt RL; et al. (2002). "Pluripotency of mesenchymal stem cells derived from adult marrow". Nature. 418 (6893): 41–9. doi:10.1038/nature00870. PMID 12077603. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  18. ^ Ratajczak MZ, Machalinski B, Wojakowski W, Ratajczak J, Kucia M (2007). "A hypothesis for an embryonic origin of pluripotent Oct-4(+) stem cells in adult bone marrow and other tissues". Leukemia. 21 (5): 860–7. doi:10.1038/sj.leu.2404630. PMID 17344915.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  19. ^ Gardner RL (2002). "Stem cells: potency, plasticity and public perception". Journal of Anatomy. 200 (3): 277–82. doi:10.1046/j.1469-7580.2002.00029.x. PMID 12033732.
  20. ^ Takahashi K, Yamanaka S (2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors". Cell. 126 (4): 663–76. doi:10.1016/j.cell.2006.07.024. PMID 16904174.
  21. ^ Barrilleaux B, Phinney DG, Prockop DJ, O'Connor KC (2006). "Review: ex vivo engineering of living tissues with adult stem cells". Tissue Eng. 12 (11): 3007–19. doi:10.1089/ten.2006.12.3007. PMID 17518617.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  22. ^ Gimble JM, Katz AJ, Bunnell BA (2007). "Adipose-derived stem cells for regenerative medicine". Circ Res. 100 (9): 1249–60. doi:10.1161/01.RES.0000265074.83288.09. PMID 17495232.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  23. ^ "Bone Marrow Transplant".
  24. ^ Kane, Ed (2008-05-01). "Stem-cell therapy shows promise for horse soft-tissue injury, disease". DVM Newsmagazine. Retrieved 2008-06-12.
  25. ^ "Stem Cell FAQ". US Department of Health and Human Services. 2004.
  26. ^ Beckmann J, Scheitza S, Wernet P, Fischer JC, Giebel B (2007). "Asymmetric cell division within the human hematopoietic stem and progenitor cell compartment: identification of asymmetrically segregating proteins". Blood. 109 (12): 5494–501. doi:10.1182/blood-2006-11-055921. PMID 17332245.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  27. ^ Xie T, Spradling A (1998). "decapentaplegic is essential for the maintenance and division of germline stem cells in the Drosophila ovary". Cell. 94 (2): 251–60. doi:10.1016/S0092-8674(00)81424-5. PMID 9695953.
  28. ^ Song X, Zhu C, Doan C, Xie T (2002). "Germline stem cells anchored by adherens junctions in the Drosophila ovary niches". Science. 296 (5574): 1855–7. doi:10.1126/science.1069871. PMID 12052957.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  29. ^ Takahashi K, Yamanaka S (2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors". Cell. 126 (4): 663–76. doi:10.1016/j.cell.2006.07.024. PMID 16904174.
  30. ^ Gahrton G, Björkstrand B (2000). "Progress in haematopoietic stem cell transplantation for multiple myeloma". J Intern Med. 248 (3): 185–201. doi:10.1046/j.1365-2796.2000.00706.x. PMID 10971785.
  31. ^ Lindvall O (2003). "Stem cells for cell therapy in Parkinson's disease". Pharmacol Res. 47 (4): 279–87. doi:10.1016/S1043-6618(03)00037-9. PMID 12644384.
  32. ^ Goldman S, Windrem M (2006). "Cell replacement therapy in neurological disease". Philos Trans R Soc Lond B Biol Sci. 361 (1473): 1463–75. doi:10.1098/rstb.2006.1886. PMID 16939969.
  33. ^ Wade N (2006-08-14). "Some Scientists See Shift in Stem Cell Hopes". New York Times. Retrieved 2006-12-28.
  34. ^ Nell Greenfieldboyce (23 August 2006). "Firm creates stem cells without hurting embryos". National Public Radio.
  35. ^ Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998). "Embryonic stem cell lines derived from human blastocysts". Science. 282 (5391). New York: 1145–7. doi:10.1126/science.282.5391.1145. PMID 9804556. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  36. ^ Cibelli JB, Lanza RP, West MD, Ezzell C (2001). "The first human cloned embryo". Scientific American. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  37. ^ Shostak S (2006). "(Re)defining stem cells". Bioessays. 28 (3): 301–8. doi:10.1002/bies.20376. PMID 16479584.
  38. ^ Takahashi K, Yamanaka S (2006). "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors". Cell. 126 (4): 663–76. doi:10.1016/j.cell.2006.07.024. PMID 16904174. {{cite journal}}: Unknown parameter |month= ignored (help)
  39. ^ "Good News for Alcoholics". 2007. {{cite web}}: |section= ignored (help); Unknown parameter |month= ignored (help); Unknown parameter |publication= ignored (help)
  40. ^ . The Scotsman http://news.scotsman.com/health.cfm?id=1608072006. {{cite news}}: Missing or empty |title= (help)
  41. ^ De Coppi P, Bartsch G, Siddiqui MM; et al. (2007). "Isolation of amniotic stem cell lines with potential for therapy". Nat Biotechnol. 25 (1): 100–6. doi:10.1038/nbt1274. PMID 17206138. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  42. ^ Karen Kaplan (8 January 2007). "Easy stem-cell source sparks interest: Researchers find amniotic fluid offers advantages". Boston Globe.
  43. ^ Cyranoski D (2007). "Simple switch turns cells embryonic". Nature. 447 (7145): 618–9. doi:10.1038/447618a. PMID 17554270.
  44. ^ Mitalipov SM, Zhou Q, Byrne JA, Ji WZ, Norgren RB, Wolf DP (2007). "Reprogramming following somatic cell nuclear transfer in primates is dependent upon nuclear remodeling". Hum Reprod. 22 (8): 2232–42. doi:10.1093/humrep/dem136. PMID 17562675.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  45. ^ "The Nobel prize in physiology or medicine 2007". Nobelprize.org. Retrieved 8 October 2007. {{cite web}}: Unknown parameter |dateformat= ignored (help)
  46. ^ Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors" (PDF). Cell. 131 (5): 861–72. doi:10.1016/j.cell.2007.11.019. PMID 18035408. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  47. ^ Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA (2007). "Induced pluripotent stem cell lines derived from human somatic cells". Science. 318 (5858): 1917–20. doi:10.1126/science.1151526. PMID 18029452. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  48. ^ Chung; et al. (2008). "Human embryonic stem cell lines generated without embryo destruction". Cell Stem Cell. 2: 113. doi:10.1016/j.stem.2007.12.013. {{cite journal}}: Explicit use of et al. in: |author= (help)
  49. ^ French AJ, Adams CA, Anderson LS, Kitchen JR, Hughes MR, Wood SH (2008-01-17). "Development of human cloned blastocysts following somatic cell nuclear transfer (SCNT) with adult fibroblasts" (PDF). Stem Cells Express. 26: 485. doi:10.1634/stemcells.2007-0252.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  50. ^ Aoi T, Yae K, Nakagawa M; et al. (2008). "Generation of pluripotent stem cells from adult mouse liver and stomach cells". Science. 321 (5889): 699–702. doi:10.1126/science.1154884. PMID 18276851. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  51. ^ The Niche: Adult cell types besides skin are reprogrammed
  52. ^ Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D (2008). "Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells". Pain Physician. 11 (3): 343–53. ISSN 1533-3159. PMID 18523506.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  53. ^ Conrad S, Renninger M, Hennenlotter J; et al. (2008). "Generation of pluripotent stem cells from adult human testis". Nature. 456 (7220): 344–9. doi:10.1038/nature07404. PMID 18849962. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  54. ^ Baker M (2008). "Embryonic-like stem cells from a single human hair". Nature Reports Stem Cells. doi:10.1038/stemcells.2008.142. {{cite journal}}: Unknown parameter |month= ignored (help)
  55. ^ Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsenstein M, Kaji K, Sung HK, Nagy A (2009-03-01). "piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells". Nature. doi:10.1038/nature07863.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  56. ^ "Canadians make stem cell breakthrough". March 1, 2009. Retrieved March 1, 2009.
  57. ^ "Researchers find new method for turning adult cells into stem cells". Canadian Press. 2009-03-02. Retrieved 2009-03-03.
  58. ^ Ian Sample (2009-03-01). "Scientists' stem cell breakthrough ends ethical dilemma". The Guardian. Retrieved 2009-03-03.
  59. ^ Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K (2009-03-01). "Virus-free induction of pluripotency and subsequent excision of reprogramming factors". Nature. doi:10.1038/nature07864.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  60. ^ "Stem cell research breakthough". The Australian. AAP. 5 March 2009.preprint abstract
  61. ^ "Obama links scientific research to protecting 'free thinking'". USA Today. 9 March 2009.[1]
  62. ^ a b "Dispatches: The Politics of Stem Cells". Nova. PBS.
  63. ^ "Missouri Constitution Amendment 2". 2006.
  64. ^ "Calif. Awards $45M in Stem Cell Grants". Associated Press. 17 February 2007.
  65. ^ "Full-text of Michigan Proposal 08-2" (PDF).
  66. ^ "Green light for US stem cell work". BBC News.
  67. ^ "Obama reverses Bush-era stem cell policy". Associated Press.
General
Peer-reviewed journals
Retrieved from "https://en.wikipedia.org/w/index.php?title=Stem_cell&oldid=281097539"